iSBTc 24th Annual Meeting
October 29 - 31, 2009
Gaylord National Hotel and Convention Center
National Harbor, MD - Washington, D.C.
A record setting number of attendees converged in Washington, D.C. for the very successful iSBTc 24th Annual Meeting October 29-31, 2009 at the Gaylord National Hotel. Over 500 scientists, clinicians, students, fellows, researchers, and industry and regulatory representatives from 27 countries attended, shared cutting-edge science, and jointly celebrated the advancement and success of the immunotherapy/biological therapy field. There was much excitement among attendees centered on the high quality science, networking opportunities, and caliber of speakers and attendees present at the iSBTc 24th Annual Meeting.
Record Setting Year!
The iSBTc 24th Annual Meeting set several records including:
- Program Attendance - over 500 attendees!
- Countries Represented - people from 27 countries were in attendance.
- Abstract Submissions - over 200 regular and late-breaking abstracts were submitted.
- Young Investigator Award Candidates - over 100 abstracts submitted for consideration.
Topics Presented / Discussed
| Adopt ive Transfer
||Monoclonal Antibodies / Combinations
|Clinical Trials of New Agents
||Regulatory & Activated T Cell Subsets
|Cytokines / Immunotherapy
||Stem Cells / Circulating Tumor Cells
|Enhancing Cancer Vaccines / Combinations
||Targeted Therapeutics & Biological Therapy
||Viral & Cellular Proteomic Targets
|Manipulation of the Tumor Microenvironment
Annual Meeting Organizers
|Lieping Chen, MD, PhD
Johns Hopkins University School of Medicince
|Giorgio Trinchieri, MD
National Cancer Institute
|Robert Ferris, MD, PhD
University of Pittsburgh Cancer Institute
|Laurence Zitvogel, MD, PhD
Institute Gustave Roussy
|Carl H. June, MD
University of Pennsylvania